MicroRNAs in cancer therapeutic response: Friend and foe

doi:10.5306/wjco.v5.i4.730

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6630)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

392

WORD

260

HTML

4193

Figures (1-1)

167

Tables (1-2)

189

Sum=5201

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

655

Download

774

Sum=1429

Oct 10, 2014 (publication date) through Sep 18, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. Oct 10, 2014; 5(4): 730-743
Published online Oct 10, 2014. doi: 10.5306/wjco.v5.i4.730

Table 2 miRNAs involved in antiendocrine therapy response in breast cancer

miRNA	Drug	Target(s)	Ref.
miR-221/222	Tamoxifen	P27Kip1	[91]
		ERα
	Fulvestrant	TGF-β	[93]
miR-181b	Tamoxifen	TIMP3	[94]
miR-30c	Tamoxifen		[96,97]
miR-342	Tamoxifen	cyclin B1	[126]
miR-451	Tamoxifen	14-3-3ζ	[127]
Let-7	Tamoxifen	ER-α36	[128]
miR-128a	Letrozole	TGFαR1	[129]

Citation: Xue J, Niu J, Wu J, Wu ZH. MicroRNAs in cancer therapeutic response: Friend and foe. World J Clin Oncol 2014; 5(4): 730-743
URL: https://www.wjgnet.com/2218-4333/full/v5/i4/730.htm
DOI: https://dx.doi.org/10.5306/wjco.v5.i4.730